MedTrace Logo

Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

NCT01429883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2015-06-03

No results posted yet for this study

Summary

Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the investigators want to ask for pain, pain reduction and function.

Conditions

  • Fasciitis, Plantar
  • Achillodynia
  • Periarthritis Calcarea
  • Epikondylopathia Humeri /Radii

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • 01 Studienregister MasterAdmins · UniversitaetsSpital Zuerich

  • Sandra Blumhardt, MD · University Hospital Zurich, Division of Rheumatology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01429883 on ClinicalTrials.gov